LAMININ ALPHA 2 IN TISSUE REGENERATION

层粘连蛋白 ALPHA 2 在组织再生中的作用

基本信息

项目摘要

DESCRIPTION: (Adapted from applicant's abstract) Tissue regeneration and repair are critical to longevity. Insufficient regeneration of muscle and nerve is a significant cause of morbidity in patients with muscular dystrophy and other muscle and nerve diseases and in the aging individual. The laminin subunit a2 is prominently expressed in striated muscle and peripheral nerve, and mutations in the lama2 gene cause a severe form of muscular dystrophy in humans (merosin-deficient congenital muscular dystrophy, MCMD) and mice. A mouse model for human MCMD was generated by disrupting the lama2 gene with the lacZ reporter gene. Homozygous mutant mice develop muscular dystrophy and peripheral neuropathy after birth. Absence of laminin a2 does not significantly affect myogenesis, but the differentiated laminin a2-deficient muscle are highly susceptible to injury upon contraction. Most important, in contrast to the apparent normal development, regeneration is severely compromised in the absence of laminin a2. It is proposed to use in vivo and in vitro models to analyze development and regeneration of skeletal muscle and peripheral nerve to determine which steps in the regeneration process are dependent on laminin a2. The regeneration-promoting effects of laminin a2 will be analyzed in transgenic mice with tissue-specific overexpression of a human LAMA2 transgene. To analyze the molecular pathways responsible for maturation and survival of skeletal muscle and Schwann cells, integrin and dystroglycan signaling pathways will be characterized by using the yeast 2-hybrid screening and affinity chromatography in combination with peptide mass mapping. The proposed research will result in new knowledge regarding important molecular mechanisms of muscle and nerve function and may help in devising new strategies for treatment of degenerative diseases of muscle and nerve based on promoting regeneration.
描述:(改编自申请人摘要)组织再生与修复

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

EVA S ENGVALL其他文献

EVA S ENGVALL的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('EVA S ENGVALL', 18)}}的其他基金

CORE--PROTEIN CHEMISTRY
核心--蛋白质化学
  • 批准号:
    6269128
  • 财政年份:
    1998
  • 资助金额:
    $ 35.17万
  • 项目类别:
ADAMS IN MUSCLE DEVELOPMENT
亚当斯在肌肉发育中的作用
  • 批准号:
    6055697
  • 财政年份:
    1998
  • 资助金额:
    $ 35.17万
  • 项目类别:
ADAMS IN MUSCLE DEVELOPMENT
亚当斯在肌肉发育中的作用
  • 批准号:
    2686089
  • 财政年份:
    1998
  • 资助金额:
    $ 35.17万
  • 项目类别:
ADAMS IN MUSCLE DEVELOPMENT
亚当斯在肌肉发育中的作用
  • 批准号:
    6375142
  • 财政年份:
    1998
  • 资助金额:
    $ 35.17万
  • 项目类别:
ADAMS IN MUSCLE DEVELOPMENT
亚当斯在肌肉发育中的作用
  • 批准号:
    6171145
  • 财政年份:
    1998
  • 资助金额:
    $ 35.17万
  • 项目类别:
CORE--PROTEIN CHEMISTRY
核心--蛋白质化学
  • 批准号:
    6236619
  • 财政年份:
    1997
  • 资助金额:
    $ 35.17万
  • 项目类别:
LAMININ ALPHA 2 IN DEVELOPMENT
层粘连蛋白 α 2 正在开发中
  • 批准号:
    2204300
  • 财政年份:
    1996
  • 资助金额:
    $ 35.17万
  • 项目类别:
LAMININ ALPHA 2 IN DEVELOPMENT
层粘连蛋白 α 2 正在开发中
  • 批准号:
    2883134
  • 财政年份:
    1996
  • 资助金额:
    $ 35.17万
  • 项目类别:
LAMININ ALPHA 2 IN TISSUE REGENERATION
层粘连蛋白 ALPHA 2 在组织再生中的作用
  • 批准号:
    6711698
  • 财政年份:
    1996
  • 资助金额:
    $ 35.17万
  • 项目类别:
LAMININ ALPHA 2 IN TISSUE REGENERATION
层粘连蛋白 ALPHA 2 在组织再生中的作用
  • 批准号:
    6520939
  • 财政年份:
    1996
  • 资助金额:
    $ 35.17万
  • 项目类别:

相似海外基金

Cellular membrane affinity chromatography kit for drug discovery
用于药物发现的细胞膜亲和层析试剂盒
  • 批准号:
    10506915
  • 财政年份:
    2021
  • 资助金额:
    $ 35.17万
  • 项目类别:
Cellular membrane affinity chromatography kit for drug discovery
用于药物发现的细胞膜亲和层析试剂盒
  • 批准号:
    10325006
  • 财政年份:
    2021
  • 资助金额:
    $ 35.17万
  • 项目类别:
SBIR Phase I: A New Class of Immobilized Metal Affinity Chromatography Resins
SBIR 第一阶段:一类新型固定金属亲和色谱树脂
  • 批准号:
    1746198
  • 财政年份:
    2018
  • 资助金额:
    $ 35.17万
  • 项目类别:
    Standard Grant
Marine speciation of nickel using immobilized nickel affinity chromatography
使用固定镍亲和色谱法测定镍的海洋形态
  • 批准号:
    512537-2017
  • 财政年份:
    2017
  • 资助金额:
    $ 35.17万
  • 项目类别:
    University Undergraduate Student Research Awards
I-Corps: Commercialization of Immobilized Metal Affinity Chromatography Resins Based on Nanomaterials
I-Corps:基于纳米材料的固定化金属亲和层析树脂的商业化
  • 批准号:
    1404605
  • 财政年份:
    2014
  • 资助金额:
    $ 35.17万
  • 项目类别:
    Standard Grant
Antibody Purification via Affinity Chromatography that Utilizes the Unconventional Nucleotide Binding Site
利用非常规核苷酸结合位点通过亲和色谱法纯化抗体
  • 批准号:
    1263713
  • 财政年份:
    2013
  • 资助金额:
    $ 35.17万
  • 项目类别:
    Continuing Grant
Development of multivalent DNA network based affinity chromatography diagnostics for isolating circulating tumour cells
开发基于多价 DNA 网络的亲和色谱诊断法,用于分离循环肿瘤细胞
  • 批准号:
    425749-2012
  • 财政年份:
    2012
  • 资助金额:
    $ 35.17万
  • 项目类别:
    Postgraduate Scholarships - Master's
Next-Generation Affinity Chromatography with PEGylated Ligands
使用聚乙二醇化配体的新一代亲和色谱法
  • 批准号:
    1159886
  • 财政年份:
    2012
  • 资助金额:
    $ 35.17万
  • 项目类别:
    Standard Grant
Immobilized zirconium ion affinity chromatography for specific enrichment of phosphoproteins
用于磷蛋白特异性富集的固定化锆离子亲和层析
  • 批准号:
    19560760
  • 财政年份:
    2007
  • 资助金额:
    $ 35.17万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Accelerating drug discovery using frontal affinity chromatography/mass spectrometry
使用正面亲和色谱/质谱加速药物发现
  • 批准号:
    234753-2000
  • 财政年份:
    2003
  • 资助金额:
    $ 35.17万
  • 项目类别:
    Collaborative Research and Development Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了